Title Image

NEWS

Imaging in support of Cancer Immunotherapy

  |   Uncategorised

The pharmaceutical company Roche and the Institute of Pharmacology and Structural Biology (IPBS) share the objective of developing cancer control strategies.

While Roche is a major player in the development of immunotherapy strategies, IPBS aims to identify and characterize new therapeutic targets in the cancer field by using the imaging resources of the TRI- Genotoul platform.

Read more.